Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A patient's perspective of partnership in the treatment of multiple sclerosis: MS regimes-An orchestrated approach.
Walking Speed and Health-Related Quality of Life in Multiple Sclerosis.
Acute Disseminated Encephalomyelitis Presenting with Hypertensive Emergency.
Preliminary study related the incidence of methylprednisolone pulse therapy in patients visited multiple sclerosis clinic located at the isfahan kashani hospital.
[Alemtuzumab for relapsing-remitting multiple sclerosis : Results of two randomized controlled phase III studies.]
Functioning assessment vs. conventional medical assessment: a comparative study on health professionals' clinical decision-making and the fit with patient's own perspective of health.
Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats.
Body composition and physical function in women with multiple sclerosis.
[Two new oral disease modifying therapies in relapsing remitting multiple sclerosis].
Immune Tolerance Induction against Experimental Autoimmune Encephalomyelitis (EAE) Using A New PLP-B7AP Conjugate that Simultaneously Targets B7/CD28 Costimulatory Signal and TCR/MHC-II Signal.
Contrast-Enhanced MR Imaging in Neuroimaging.
Clinical features of Chinese patients with multiple sclerosis with aquaporin-4 antibodies in cerebrospinal fluid but not serum.
Chronic cerebrospinal venous insufficiency in multiple sclerosis: a highly prevalent age-dependent phenomenon.
Cognitive Processing Speed is Related to Fall Frequency in Older Adults with Multiple Sclerosis.
Cytomegalovirus ischemic colitis and transverse myelitis in a renal transplant recipient.
Vitamin D and the central nervous system.
Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients.
Ozanimod: a better or just another S1P receptor modulator?
Sphingosine-1-phosphate receptor inhibition prevents denervation-induced dendritic atrophy.
PERK-opathies: an endoplasmic reticulum stress mechanism underlying neurodegeneration.
Elevated serum levels of lysophosphatidic acid in patients with multiple sclerosis.
Serum Arsenic and Lipid Peroxidation Levels in Patients with Multiple Sclerosis.
PSGL-1 and E/P-selectins are essential for T-cell rolling in inflamed CNS microvessels but dispensable for initiation of EAE.
Quality of life in Polish patients with multiple sclerosis.
Extensive cerebral white matter involvement in a patient with NMO spectrum disorder.
Pages
« first
‹ previous
…
497
498
499
500
501
502
503
504
505
…
next ›
last »